World News Story 3rd Fda Panelist Resigns Over Approval Of Alzheimer S Drug
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, World News Story 3rd Fda Panelist Resigns Over Approval Of Alzheimer S Drug is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
FDA’s drug division chief resigns amid ethics concerns, lawsuit
The director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ... Read More
US FDA's newly appointed drugs chief set to retire
The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to exit the health agency weeks after taking the job, STAT News reported on ... Read More
FDA’s top drug regulator resigns amid investigation
George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug Evaluation and Research, resigned Nov. 2 after being placed on administrative leave, The New York Times reported Nov. 2. “The effort was ... Read More
Top FDA Drug Chief Resigns While Under Investigation
TUESDAY, Nov. 4, 2025 (HealthDay News) — The head of the U.S. Food and Drug Administration’s (FDA) drug division has resigned while under internal investigation, saying he was pushed out after raising ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus